Asahi Kasei Corporation (TYO:3407)
1,542.00
+22.50 (1.48%)
Apr 28, 2026, 3:30 PM JST
Asahi Kasei Employees
Asahi Kasei had 50,352 employees as of March 31, 2025. The number of employees increased by 1,057 or 2.14% compared to the previous year.
Employees
50,352
Change (1Y)
1,057
Growth (1Y)
2.14%
Revenue / Employee
60.36M JPY
Profits / Employee
3.12M JPY
Market Cap
2,091.64B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Nippon Sanso Holdings | 19,754 |
| Resonac Holdings | 21,525 |
| Mitsubishi Chemical Group | 63,258 |
| Nissan Chemical | 3,283 |
| Sumitomo Chemical Company | 29,279 |
| Tosoh | 14,813 |
| Kuraray | 12,117 |
| Nagase & | 7,484 |
Asahi Kasei News
- 8 days ago - Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy - Business Wire
- 8 days ago - Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases - Business Wire
- 5 weeks ago - Chevron Technology Ventures, Asahi Kasei Invest in Heavy-Industry Robotics Company KEWAZO - Business Wire
- 6 weeks ago - Asahi Kasei Begins Installation of Containerized Alkaline-Water Electrolyzer at Finland's First Commercial Hydrogen Refueling Station - Business Wire
- 2 months ago - Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris - Business Wire
- 2 months ago - Asahi Kasei to Acquire Aicuris to Accelerate Growth in Severe Infectious Diseases - GlobeNewsWire
- 2 months ago - Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds - Business Wire
- 2 months ago - Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases - Business Wire